卵巢癌死亡率高，免疫检查点抑制剂治疗效果不佳且副作用大。研究人员利用腺相关病毒 - 成簇规律间隔短回文重复序列 / Cas9 ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Clustered regularly interspaced short palindromic repeats (CRISPR)-associated ... associated virus/AAV, capsids, herpes simplex virus/HSV, and virus-like particles/VLPs) delivery has played ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

Their results are published in Nature. "Our study is a first step in dramatically expanding our repertoire of effective and safe CRISPR-Cas9 enzymes. In our manuscript we demonstrate the utility ...

Hathway’s technology uses natural epigenetic processes to dial gene activity up or down, rather than rewriting the genetic ...

The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

Many gene therapies rely on an adeno-associated virus (AAV) to deliver a therapeutic gene. To help quantify that delivery, Thermo Fisher developed its AAV genomic titer dPCR assay. Still ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...